Kanoo Hosoki

566 total citations
64 papers, 481 citations indexed

About

Kanoo Hosoki is a scholar working on Molecular Biology, Physiology and Biochemistry. According to data from OpenAlex, Kanoo Hosoki has authored 64 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Physiology and 12 papers in Biochemistry. Recurrent topics in Kanoo Hosoki's work include Eicosanoids and Hypertension Pharmacology (9 papers), Receptor Mechanisms and Signaling (9 papers) and Nitric Oxide and Endothelin Effects (8 papers). Kanoo Hosoki is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (9 papers), Receptor Mechanisms and Signaling (9 papers) and Nitric Oxide and Endothelin Effects (8 papers). Kanoo Hosoki collaborates with scholars based in Japan. Kanoo Hosoki's co-authors include Naoyuki Yoshida, Takashi Yoshikawa, Shigeru Kurooka, Y. Yoshimura, Hiroshi Minato, Tadahiko Karasawa, R. Nagai, Toshiaki Kadokawa, K Takeyama and Yuichi Masuda and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Life Sciences and European Journal of Pharmacology.

In The Last Decade

Kanoo Hosoki

62 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kanoo Hosoki Japan 11 174 100 93 91 79 64 481
Soter Dai Hong Kong 14 161 0.9× 103 1.0× 59 0.6× 132 1.5× 69 0.9× 41 554
S. Dai Hong Kong 13 108 0.6× 62 0.6× 42 0.5× 78 0.9× 39 0.5× 33 398
Päivi Holm Finland 11 171 1.0× 51 0.5× 34 0.4× 171 1.9× 30 0.4× 18 539
Antonio Esteras Spain 10 242 1.4× 72 0.7× 47 0.5× 150 1.6× 9 0.1× 16 619
Lei‐Ming Ren China 15 237 1.4× 66 0.7× 108 1.2× 159 1.7× 12 0.2× 74 605
Leonor Rivera‐Calimlim United States 15 101 0.6× 38 0.4× 20 0.2× 56 0.6× 33 0.4× 37 877
R. A. Hebden Canada 9 103 0.6× 50 0.5× 191 2.1× 167 1.8× 6 0.1× 12 446
Khodadad Namiranian Iran 15 169 1.0× 57 0.6× 79 0.8× 178 2.0× 10 0.1× 32 643
Clinton N. Corder United States 15 191 1.1× 159 1.6× 172 1.8× 179 2.0× 6 0.1× 50 809
Toshiaki Amamoto Japan 14 162 0.9× 81 0.8× 12 0.1× 40 0.4× 42 0.5× 21 578

Countries citing papers authored by Kanoo Hosoki

Since Specialization
Citations

This map shows the geographic impact of Kanoo Hosoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanoo Hosoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanoo Hosoki more than expected).

Fields of papers citing papers by Kanoo Hosoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kanoo Hosoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanoo Hosoki. The network helps show where Kanoo Hosoki may publish in the future.

Co-authorship network of co-authors of Kanoo Hosoki

This figure shows the co-authorship network connecting the top 25 collaborators of Kanoo Hosoki. A scholar is included among the top collaborators of Kanoo Hosoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kanoo Hosoki. Kanoo Hosoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hosoki, Kanoo, Akiko Obata, & Toshihiro Kasuga. (2024). Formation of Amorphous Calcium Phosphate on Strontium-Containing Calcium Carbonate (Aragonite). MATERIALS TRANSACTIONS. 66(2). 259–264.
2.
Yoshikawa, Takashi, et al.. (1998). Affinity of Mosapride Citrate, a New Gastroprokinetic Agent, for 5-HT4 Receptors in Guinea Pig Ileum. The Japanese Journal of Pharmacology. 77(1). 53–60. 35 indexed citations
3.
4.
Hosoki, Kanoo, et al.. (1998). The novel anticonvulsant zonisamide prevents dopaninergic neurodegeneration induced by MPTP. The Japanese Journal of Pharmacology. 76. 119–119. 1 indexed citations
5.
Yoshikawa, Takashi, Naoyuki Yoshida, & Kanoo Hosoki. (1996). Involvement of dopamine D3 receptors in the area postrema in R(+)-7-OH-DPAT-induced emesis in the ferret. European Journal of Pharmacology. 301(1-3). 143–149. 40 indexed citations
6.
Minato, Hiroshi, Yayoi Honda, Yuichi Masuda, Buichi Fujitani, & Kanoo Hosoki. (1996). Prevention by the new Ca2+ channel antagonist, AJ-3941, of loss of endothelium-dependent relaxation after subarachnoid hemorrhage in rats. European Journal of Pharmacology. 315(3). 297–303. 7 indexed citations
7.
Sugimoto, Tadanori, Kanoo Hosoki, & Tadahiko Karasawa. (1995). Relative Contribution of α1-Adrenoceptor Blocking Activity to the Hypotensive Effect of the Novel Calcium Antagonist Monatepil. Journal of Cardiovascular Pharmacology. 26(1). 55–60. 5 indexed citations
8.
Minato, Hiroshi, Makoto Hashizume, Yuichi Masuda, & Kanoo Hosoki. (1995). Modulation of extraluminally induced vasoconstrictions by endothelium-derived nitric oxide in the canine basilar artery.. PubMed. 45(6). 675–8. 10 indexed citations
9.
Matsumura, Yasushi, Takashi Shimada, Takeyoshi Nakayama, et al.. (1995). Novel Fluoroprostacyclin Analogs with Modified Cycloalkylenyl Chains. Highly Potent and Orally Active Anti-anginal Agents.. Chemical and Pharmaceutical Bulletin. 43(2). 353–355. 9 indexed citations
10.
Notake, Mitsue, et al.. (1994). Up-Regulation of Hepatic LDL Receptor Gene Expression by Monatepil, a Novel Calcium Antagonist, in High Cholesterol Diet-Fed Japanese Monkeys. American Journal of Hypertension. 7(11). 1026–1030. 3 indexed citations
11.
Kataoka, Takeshi, et al.. (1993). Effects of the new calcium antagonist monatepil on cardiac function and myocardial oxygen supply and demand in animals.. PubMed. 43(12). 1303–9. 2 indexed citations
12.
Yamada, Tomoko, et al.. (1993). Inhibitory Effect of the New Calcium Antagonist AJ-2615 on Progression of Atherosclerosis in Cholesterol-fed Rabbits. Journal of Cardiovascular Pharmacology. 21(4). 663–669. 6 indexed citations
13.
Takeyama, Kunihiko, et al.. (1993). Antihypertensive Effects of AJ-2615, a New Calcium Antagonist with α1-Adrenergic Blocking Activity in Experimental Hypertensive Animals. Journal of Cardiovascular Pharmacology. 21(5). 815–821. 8 indexed citations
14.
Yamamoto, Taku, Kanoo Hosoki, & Tadahiko Karasawa. (1993). Possible involvement of endothelin in thromboxane A2 receptor agonist (U-46619)-induced angina in the rat. European Journal of Pharmacology. 250(1). 189–191. 5 indexed citations
15.
Yamamoto, Taku, et al.. (1993). PREVENTIVE EFFECT OF A NEW CALCIUM ANTAGONIST, MONATEPIL, ON DRUG‐INDUCED ISCHAEMIC ELECTROCARDIOGRAPHIC CHANGES IN RATS. Clinical and Experimental Pharmacology and Physiology. 20(11). 673–678. 5 indexed citations
16.
Takeyama, Kunihiko, et al.. (1989). Antihypertensive effect of AJ-2615, a novel calcium entry blocker, in experimental hypertensive rats and dogs. The Japanese Journal of Pharmacology. 49. 211–211. 3 indexed citations
17.
Matsumoto, Kunio, et al.. (1986). Tissue levels, tissue angiotensin converting enzyme inhibition and antihypertensive effect of the novel antihypertensive agent alacepril in renal hypertensive rats.. PubMed. 36(1). 47–51. 4 indexed citations
18.
Hosoki, Kanoo, et al.. (1986). Effect of alacepril on renin-angiotensin-aldosterone system and kallikrein-kinin-prostaglandin system in experimental animals.. PubMed. 36(1). 77–83. 7 indexed citations
19.
Takeyama, Kunihiko, et al.. (1984). Renal excretion mechanism of at-2266 in dogs. Chemotherapy. 32. 154–158. 2 indexed citations
20.
Hosoki, Kanoo, Mizuo Miyazaki, & Kengo Yamamoto. (1977). Renin inhibitory effect of 2-[4-(4'-chlorophenoxy)phenoxyacetylamino]-ethylphosphorylethanolamine (PE-104) in vitro and in vivo.. Journal of Pharmacology and Experimental Therapeutics. 203(2). 485–492. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soter Dai Breakdown of academic impact, for papers by S. Dai Breakdown of academic impact, for papers by Päivi Holm Breakdown of academic impact, for papers by Antonio Esteras Breakdown of academic impact, for papers by Lei‐Ming Ren Breakdown of academic impact, for papers by Leonor Rivera‐Calimlim Breakdown of academic impact, for papers by R. A. Hebden Breakdown of academic impact, for papers by Khodadad Namiranian Breakdown of academic impact, for papers by Clinton N. Corder Breakdown of academic impact, for papers by Toshiaki Amamoto
Rankless by CCL
2026